Additional European Equity News

AstraZeneca (AZN LN) - Engertu approved in the EU for post-ET breast cancer; demonstrates superiority over chemotherapy in the DESTINY-Breast06 trial with a 38% reduction in the risk of disease progression or death; Daiichi Sankyo to receive USD 125 million for approval, which comes in addition to the 2019 upfront payment. (Newswires)

BP (BP/ LN) - Co. says Chairman Helge will step down in "due course"; succession process will be led by Amanda Blanc. (Newswires) 

Scor (SCR FP) - Placed under examination fo facts alleged against former Chair. (Newswires)

Santander (SAN SM) - Expects continued growth in Q1; expects CET1 rising to 12.9% in Q1. Affirms all 2025 targets. (Newswires) 

THG (THG LN) - Completion of debt refinancing; EUR 445mln term loan B extended to Dec 29. (Newswires)